Trades on 1 secondary market

AbogenBio

Abogen Biosciences (Suzhou Abogen Biosciences, 苏州艾博生物科技有限公司) is an industry-leading clinical-stage biotech company founded in January 2019 and headquartered in Suzhou, China, dedicated to developing transformative medicines through messenger RNA (mRNA) innovation. The company has built full-scale in

emerging 15.0 / 100 0 APIs View provider profile →

Company Biotechnology mRNA Pharmaceuticals Vaccines Life Sciences

AbogenBio is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.